Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences

Report Code: BIO114B

Publish Date: Aug 2014

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.

Report Includes

  • An overview of the global market for particle size analysis instrumentation used in the life sciences, including salient production technologies, geographies, and factors influencing demand.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Examination of how the development of nanoparticles and their rapid incorporation into the research and development, formulation, and production of drug products has led to the need for rapid and accurate analytical instrumentation for determining the size and characteristics of various particle materials in the nanometer size range.
  • Discussion of how growth in the industry is due to the availability of microchips, smaller circuit boards, and a variety of other advances in the overall electronic and digital imaging areas that have occurred in the last decade.
  • A breakdown of particle analysis products, including size analysis, shape analysis, molecular weight analysis, flow analysis, solubility analysis, zeta potential analysis, and molecular structure analysis.
  • Relevant patent analysis.

Report Scope

Current and projected product forecasts during the forecast period (2014 to 2019) are discussed. New product launches will be discussed. Revenue figures for 2013 are actual figures, except where actual results have not been reported, due to the timing of the release of this report.

The report includes analysis of leading and emerging nanoparticle instrumentation categories. Profiles of manufacturers of leading products and their specific products are provided. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.

Market figures are based on revenues at the manufacturers’ level and are projected at 2013-dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products and other factors affecting the market.

Included in this report are forecasts by product, product category and by company from 2012 through 2019. The study is arranged to offer an overview of existing nanoparticle instrumentation technology, company, geography and mechanism of analysis with forecasts broken down and covered by geographic region or country.

Patent information is reviewed for various technologies. The status of approvals by regulatory agencies, where appropriate, is reviewed.

Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.

All market share data presented is on a global basis, unless specifically noted.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007. Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development. Jackson Highsmith is a pseudonym of the author.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences166Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW13Free
Chapter- 4: GLOBAL LIFE SCIENCES MARKET FOR NANOPARTICLE ANALYSIS INSTRUMENTATION6Free
Chapter- 5: PARTICLE SIZE ANALYSIS20Free
Chapter- 6: NANOPARTICLE SHAPE ANALYSIS IN LIFE SCIENCES18Free
Chapter- 7: MOLECULAR WEIGHT ANALYSIS IN THE LIFE SCIENCES7Free
Chapter- 8: FLOW PROPERTIES OF NANOPARTICLES IN THE LIFE SCIENCES4Free
Chapter- 9: MOLECULAR STRUCTURE/IMAGING OF NANOPARTICLE IN THE LIFE SCIENCES22Free
Chapter- 10: TRENDS AND OPPORTUNITIES IN NANOPARTICLE INSTRUMENTATION3Free
Chapter- 11: GLOBAL DEMAND FOR NANOPARTICLE ANALYSIS INSTRUMENTATION IN LIFE SCIENCES4Free
Chapter- 12: NANOPARTICLE INSTRUMENT AND ASSOCIATED PATENTS2Free
Chapter- 13: DRUG CLINICAL TRIALS WITH NANOPARTICLE DRUGS17Free
Chapter- 14: NANOPARTICLE MERGERS AND ACQUISITIONS5Free
Chapter- 15: C. CRAMER & CO. GMBH38Free
Published - Jan-2013| Analyst - Jackson Highsmith| Code - BIO114A

Report Highlights

The global market for nanoparticle analysis equipment was valued at nearly $5.2 billion in 2011 and is expected to reach $5.3 billion in 2012. Total market value is expected to reach $6.8 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5.1%.

Report Includes

  • An overview of the global market for particle size analysis instrumentation used in the life sciences, including salient production technologies, geographies, and factors influencing demand
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Examination of how the development of nanoparticles and their rapid incorporation into the research and development, formulation, and production of drug products has led to the need for rapid and accurate analytical instrumentation for determining the size and characteristics of various particle materials in the nanometer size range
  • Discussion of how growth in the industry is due to the availability of microchips, smaller circuit boards, and a variety of other advances in the overall electronic and digital imaging areas that have occurred in the last decade
  • A breakdown of particle analysis products, including size analysis, shape analysis, molecular weight analysis, flow analysis, solubility analysis, zeta potential analysis, and molecular structure analysis
  • Comprehensive company profiles of major players in the industry
  • Patent analyses.

Related Reports

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

Published - Sep 2012 | Publisher - Jackson Highsmith | Code - BIO113A

The global market for nanoparticles in biotechnology, drug development and drug delivery was valued at $17.5 billion in 2011 and should reach nearly $21.6 billion in 2012. Total market value is expected to reach $53.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.9%.

Nanotechnology: A Realistic Market Assessment

Published - Sep 2012 | Publisher - Andrew McWilliams | Code - NAN031E

The global market for nanotechnology was valued at nearly $20.1 billion in 2011 and should reach $20.7 billion in 2012. Total sales are expected to reach $48.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 18.7%.

Global Markets and Technologies for Carbon Nanotubes

Published - Jul 2012 | Publisher - John Oliver | Code - NAN024E

The global market for various carbon nanotubes (CNT) grades was $192 million in 2011. In 2012, it is estimated to generate nearly $239 million in revenues, and projected to grow over the next five years at a compound annual growth rate (CAGR) of 22.4%, reaching $527 million by 2016.

Genitourinary Drugs: Technologies and Global Markets

Published - Jun 2012 | Publisher - Jackson Highsmith | Code - PHM115A

The total market for genitourinary drugs is projected to increase from $26.5 billion in 2011 to $30.7 billion in 2016 at a compound annual growth rate (CAGR) of 3% for a period of five years, from 2011 to 2016.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences
Customize Report